VanEck Biotech ETF (BBH)
NasdaqGM: BBH
· Real-Time Price · USD
242.35
-1.13 (-0.46%)
At close: Aug 26, 2026, 11:02 AM
VanEck Biotech ETF (BBH) ETF Price, Holdings & Analysis
-0.46% (1D)
| Bid | 210.43 |
| Market Cap | n/a |
| AUM | 399.88M |
| NAV | 240.10 |
| Beta | 0.55 |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | 29.81 |
| Shares Out | n/a |
| Inception Date | Dec 20, 2011 |
| Ask | 210.68 |
| Volume | 2,232 |
| Avg. Volume (20D) | 5,825 |
| Open | 242.41 |
| Previous Close | 243.48 |
| Day's Range | 242.26 - 242.41 |
| 52-Week Range | 160.91 - 244.35 |
| Holdings | n/a |
| Expense Ratio | 0.35% |
About BBH
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Asset Class Equity
Ticker Symbol BBH
Inception Date Dec 20, 2011
Provider Vaneck
Website Fund Home Page
Exchange NasdaqGM
Top 10 Holdings 71.57% of assets
| Name | Symbol | Weight |
|---|---|---|
| Amgen Inc | AMGN | 15.95% |
| Gilead Sciences Inc | GILD | 12.98% |
| Vertex Pharmaceutica... | VRTX | 8.63% |
| Regeneron Pharmaceut... | REGN | 7.18% |
| Revolution Medicines... | RVMD | 5.29% |
| Iqvia Holdings Inc | IQV | 5.18% |
| Natera Inc | NTRA | 4.77% |
| Argenx Se Adr | ARGX | 4.57% |
| Illumina Inc | ILMN | 3.61% |
| Biogen Inc | BIIB | 3.41% |
Dividends Dividend Yield 0.39%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 22, 2025 | $0.9570 | n/a |
| Dec 23, 2024 | $1.2520 | n/a |
| Dec 18, 2023 | $0.7130 | n/a |
| Dec 19, 2022 | $0.7490 | n/a |
| Dec 20, 2021 | $0.3970 | n/a |
Page 1 of 2